178 related articles for article (PubMed ID: 22579806)
1. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB
Cancer Lett; 2012 Nov; 324(1):66-74. PubMed ID: 22579806
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
[TBL] [Abstract][Full Text] [Related]
3. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
4. RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.
Fang EF; Zhang CZ; Fong WP; Ng TB
Apoptosis; 2012 Apr; 17(4):377-87. PubMed ID: 22134530
[TBL] [Abstract][Full Text] [Related]
5. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Fan X; He L; Meng Y; Li G; Li L; Meng Y
Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
[TBL] [Abstract][Full Text] [Related]
6. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition by pennogenyl saponins from Rhizoma paridis on hepatoma xenografts in nude mice.
Chen YS; He Y; Chen C; Zeng Y; Xue D; Wen FY; Wang L; Zhang H; Du JR
Steroids; 2014 May; 83():39-44. PubMed ID: 24530287
[TBL] [Abstract][Full Text] [Related]
8. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro.
Li M; Li Q; Zhang YH; Tian ZY; Ma HX; Zhao J; Xie SQ; Wang CJ
Anticancer Drugs; 2013 Jan; 24(1):32-42. PubMed ID: 23032518
[TBL] [Abstract][Full Text] [Related]
10. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic and anti-angiogenic effects of Pulsatilla koreana extract on hepatocellular carcinoma.
Hong SW; Jung KH; Lee HS; Choi MJ; Zheng HM; Son MK; Lee GY; Hong SS
Int J Oncol; 2012 Feb; 40(2):452-60. PubMed ID: 21935571
[TBL] [Abstract][Full Text] [Related]
13. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
[TBL] [Abstract][Full Text] [Related]
14. Ribosome-inactivating Protein MAP30 Isolated from
Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma.
Li X; Zeng X; Sun J; Li H; Wu P; Fung KP; Liu F
Cancer Lett; 2014 Jun; 348(1-2):146-55. PubMed ID: 24680709
[TBL] [Abstract][Full Text] [Related]
16. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
17. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
18. Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo.
Fang EF; Zhang CZ; Ng TB; Wong JH; Pan WL; Ye XJ; Chan YS; Fong WP
Cancer Prev Res (Phila); 2012 Jan; 5(1):109-21. PubMed ID: 21933914
[TBL] [Abstract][Full Text] [Related]
19. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
20. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
